missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ SPRY2 Recombinant Rabbit Monoclonal Antibody (24GB2525)

Rabbit Recombinant Monoclonal Antibody
Marke: Invitrogen™ MA557263
Dieser Artikel kann nicht zurückgegeben werden.
Rückgaberichtlinie anzeigen
Beschreibung
SPRY2 Recombinant Monoclonal Antibody for Western Blot, ICC/IF, Flow
This gene encodes a protein belonging to the sprouty family. The encoded protein contains a carboxyl-terminal cysteine-rich domain essential for the inhibitory activity on receptor tyrosine kinase signaling proteins and is required for growth factor stimulated translocation of the protein to membrane ruffles. In primary dermal endothelial cells this gene is transiently upregulated in response to fibroblast growth factor two. This protein is indirectly involved in the non-cell autonomous inhibitory effect on fibroblast growth factor two signaling. The protein interacts with Cas-Br-M (murine) ectropic retroviral transforming sequence, and can function as a bimodal regulator of epidermal growth factor receptor/mitogen-activated protein kinase signaling. This protein may play a role in alveoli branching during lung development as shown by a similar mouse protein.
Spezifikation
| SPRY2 | |
| Recombinant Monoclonal | |
| 0.4 mg/mL | |
| PBS with 50% glycerol and 0.02% sodium azide; pH 7.4 | |
| O43597 | |
| SPRY2 | |
| A synthesized peptide derived from human Sprouty 2 (aa 250-315). | |
| 100 μL | |
| Primary | |
| Human | |
| Antibody | |
| IgG |
| Flow Cytometry, Western Blot, Immunocytochemistry | |
| 24GB2525 | |
| Unconjugated | |
| SPRY2 | |
| hSPRY2; IGAN3; MGC23039; protein sprouty homolog 2; sprouty 2; sprouty homolog 2; sprouty homolog 2 (Drosophila); sprouty RTK signaling antagonist 2; sprouty2; SPRY2; spry-2 | |
| Rabbit | |
| Affinity chromatography | |
| RUO | |
| 10253 | |
| -20°C | |
| Liquid |
Berichtigung von Produktinhalten
Bitte geben Sie uns Ihr Feedback zu den Produktinhalten, indem Sie das folgende Formular ausfüllen.
Name des Produkts
Haben Sie Verbesserungsvorschläge?Übermitteln Sie eine inhaltliche Korrektur